Neurodiagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
1. EXECUTIVE SUMMARY
2. GLOBAL NEURODIAGNOSTICS MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Neurodiagnostics Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Neurodiagnostics Market by Product
3.3.1: Introduction
3.3.2: Diagnostic and Imaging Systems
3.3.3: Clinical Testing Instruments
3.3.4: Reagents & Consumables
3.4: Global Neurodiagnostics Market by Condition
3.4.1: Neuro Degenerative Diseases
3.4.2: Epilepsy
3.4.3: Stroke
3.4.4: Headache Disorders
3.4.5: Sleep Disorders
3.4.6: Others
3.5: Global Neurodiagnostics Market by End Use
3.5.1: Hospitals and Surgery Centers
3.5.2: Neurology Centers
3.5.3: Ambulatory Care Centers
3.5.4: Diagnostic Laboratories & Imaging Centers
3.5.5: Research Laboratories & Academic Institutes
3.5.6: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Neurodiagnostics Market by Region
4.2: North American Neurodiagnostics Market
4.2.1: North American Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
4.2.2: North American Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others
4.3: European Neurodiagnostics Market
4.3.1: European Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
4.3.2: European Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others
4.4: APAC Neurodiagnostics Market
4.4.1: APAC Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
4.4.2: APAC Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others
4.5: ROW Neurodiagnostics Market
4.5.1: ROW Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
4.5.2: ROW Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Neurodiagnostics Market by Product
6.1.2: Growth Opportunities for the Global Neurodiagnostics Market by Condition
6.1.3: Growth Opportunities for the Global Neurodiagnostics Market by End Use
6.1.4: Growth Opportunities for the Global Neurodiagnostics Market by Region
6.2: Emerging Trends in the Global Neurodiagnostics Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Neurodiagnostics Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neurodiagnostics Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: GE Healthcare
7.2: Siemens Healthineers
7.3: Philips Healthcare
7.4: Canon
7.5: Hitachi
7.6: Lifelines Neuro Company
7.7: Natus Medical
7.8: Hoffman-La Roche
7.9: FUJIFILM Holdings
7.10: Mitsar
2. GLOBAL NEURODIAGNOSTICS MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Neurodiagnostics Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Neurodiagnostics Market by Product
3.3.1: Introduction
3.3.2: Diagnostic and Imaging Systems
3.3.3: Clinical Testing Instruments
3.3.4: Reagents & Consumables
3.4: Global Neurodiagnostics Market by Condition
3.4.1: Neuro Degenerative Diseases
3.4.2: Epilepsy
3.4.3: Stroke
3.4.4: Headache Disorders
3.4.5: Sleep Disorders
3.4.6: Others
3.5: Global Neurodiagnostics Market by End Use
3.5.1: Hospitals and Surgery Centers
3.5.2: Neurology Centers
3.5.3: Ambulatory Care Centers
3.5.4: Diagnostic Laboratories & Imaging Centers
3.5.5: Research Laboratories & Academic Institutes
3.5.6: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Neurodiagnostics Market by Region
4.2: North American Neurodiagnostics Market
4.2.1: North American Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
4.2.2: North American Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others
4.3: European Neurodiagnostics Market
4.3.1: European Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
4.3.2: European Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others
4.4: APAC Neurodiagnostics Market
4.4.1: APAC Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
4.4.2: APAC Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others
4.5: ROW Neurodiagnostics Market
4.5.1: ROW Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
4.5.2: ROW Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Neurodiagnostics Market by Product
6.1.2: Growth Opportunities for the Global Neurodiagnostics Market by Condition
6.1.3: Growth Opportunities for the Global Neurodiagnostics Market by End Use
6.1.4: Growth Opportunities for the Global Neurodiagnostics Market by Region
6.2: Emerging Trends in the Global Neurodiagnostics Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Neurodiagnostics Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neurodiagnostics Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: GE Healthcare
7.2: Siemens Healthineers
7.3: Philips Healthcare
7.4: Canon
7.5: Hitachi
7.6: Lifelines Neuro Company
7.7: Natus Medical
7.8: Hoffman-La Roche
7.9: FUJIFILM Holdings
7.10: Mitsar
